CODE,DESCRIPTION
D61,Other aplastic anaemias
D61.0,Constitutional aplastic anaemia
D61.1,Drug-induced aplastic anaemia
D61.2,Aplastic anaemia due to other external agents
D61.3,Idiopathic aplastic anaemia
D61.8,Other specified aplastic anaemias
D61.9,"Aplastic anaemia, unspecified"
T86.0,Bone-marrow transplant rejection
T45.1,Poisoning: Antineoplastic and immunosuppressive drugs
U85,Resistance to antineoplastic drugs
Y43.1,Antineoplastic antimetabolites
Y43.2,Antineoplastic natural products
Y43.3,Other antineoplastic drugs
Z08.1,Follow-up examination after radiotherapy for malignant neoplasm
Z08.2,Follow-up examination after chemotherapy for malignant neoplasm
Z08.7,Follow-up examination after combined treatment for malignant neoplasm
Z09.1,Follow-up examination after radiotherapy for other conditions
Z09.2,Follow-up examination after chemotherapy for other conditions
Z29.2,Other prophylactic chemotherapy
Z51.0,Radiotherapy session
Z51.1,Chemotherapy session for neoplasm
Z51.2,Other chemotherapy
Z54.1,Convalescence following radiotherapy
Z54.2,Convalescence following chemotherapy
Z54.7,Convalescence following combined treatment
,
,
,
,
,
,
,
,
,
,
,
,
,
,
B20,Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
B20.0,HIV disease resulting in mycobacterial infection
B20.1,HIV disease resulting in other bacterial infections
B20.2,HIV disease resulting in cytomegaloviral disease
B20.3,HIV disease resulting in other viral infections
B20.4,HIV disease resulting in candidiasis
B20.5,HIV disease resulting in other mycoses
B20.6,HIV disease resulting in Pneumocystis jirovecii pneumonia
B20.7,HIV disease resulting in multiple infections
B20.8,HIV disease resulting in other infectious and parasitic diseases
B20.9,HIV disease resulting in unspecified infectious or parasitic disease
B21,Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms
B21.0,HIV disease resulting in Kaposi sarcoma
B21.1,HIV disease resulting in Burkitt lymphoma
B21.2,HIV disease resulting in other types of non-Hodgkin lymphoma
B21.3,"HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue"
B21.7,HIV disease resulting in multiple malignant neoplasms
B21.8,HIV disease resulting in other malignant neoplasms
B21.9,HIV disease resulting in unspecified malignant neoplasm
B22,Human immunodeficiency virus [HIV] disease resulting in other specified diseases
B22.0,HIV disease resulting in encephalopathy
B22.1,HIV disease resulting in lymphoid interstitial pneumonitis
B22.2,HIV disease resulting in wasting syndrome
B22.7,HIV disease resulting in multiple diseases classified elsewhere
B23,Human immunodeficiency virus [HIV] disease resulting in other conditions
B23.0,Acute HIV infection syndrome
B23.1,HIV disease resulting in (persistent) generalized lymphadenopathy
B23.2,"HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified"
B23.8,HIV disease resulting in other specified conditions
B24,Unspecified human immunodeficiency virus [HIV] disease
F02.4,Dementia in human immunodeficiency virus [HIV] disease
O98.7,"Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium"
R75,Laboratory evidence of human immunodeficiency virus [HIV]
Z21,Asymptomatic human immunodeficiency virus [HIV] infection status
B21.1,HIV disease resulting in Burkitt lymphoma
B21.2,HIV disease resulting in other types of non-Hodgkin lymphoma
B21.3,"HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue"
C81,Hodgkin lymphoma
C81.0,Nodular lymphocyte predominant Hodgkin lymphoma
C81.1,Nodular sclerosis (classical) Hodgkin lymphoma
C81.2,Mixed cellularity (classical) Hodgkin lymphoma
C81.3,Lymphocyte depleted (classical) Hodgkin lymphoma
C81.4,Lymphocyte-rich (classical) Hodgkin lymphoma
C81.7,Other (classical) Hodgkin lymphoma
C81.9,"Hodgkin lymphoma, unspecified"
C82,Follicular lymphoma
C82.0,Follicular lymphoma grade I
C82.1,Follicular lymphoma grade II
C82.2,"Follicular lymphoma grade III, unspecified"
C82.3,Follicular lymphoma grade IIIa
C82.4,Follicular lymphoma grade IIIb
C82.5,Diffuse follicle centre lymphoma
C82.6,Cutaneous follicle centre lymphoma
C82.7,Other types of follicular lymphoma
C82.9,"Follicular lymphoma, unspecified"
C83,Non-follicular lymphoma
C83.0,Small cell B-cell lymphoma
C83.1,Mantle cell lymphoma
C83.2,Diffuse non-Hodgkin mixed sml & lge cell (diffuse) lymphoma
C83.3,Diffuse large B-cell lymphoma
C83.4,Diffuse non-Hodgkin's immunoblastic (diffuse) lymphoma
C83.5,Lymphoblastic (diffuse) lymphoma
C83.6,Diffuse non-Hodgkin's lymphoma undifferentiated (diffuse)
C83.7,Burkitt lymphoma
C83.8,Other non-follicular lymphoma
C83.9,"Non-follicular (diffuse) lymphoma, unspecified"
C84,Mature T/NK-cell lymphomas
C84.0,Mycosis fungoides
C84.1,S├®zary disease
C84.2,"Peripheral and cutaneous T-cell lymphomas, T-zone lymphoma"
C84.3,"Periph & cutan T-cell lymphomas, lymphoepithelioid lymphoma"
C84.4,"Peripheral T-cell lymphoma, not elsewhere classified"
C84.5,Other mature T/NK-cell lymphomas
C84.6,"Anaplastic large cell lymphoma, ALK-positive"
C84.7,"Anaplastic large cell lymphoma, ALK-negative"
C84.8,"Cutaneous T-cell lymphoma, unspecified"
C84.9,"Mature T/NK-cell lymphoma, unspecified"
C85,Other and unspecified types of non-Hodgkin lymphoma
C85.0,"Oth & unspec types of non-Hodgkin's lymphoma, lymphosarcoma"
C85.1,"B-cell lymphoma, unspecified"
C85.2,Mediastinal (thymic) large B-cell lymphoma
C85.7,Other specified types of non-Hodgkin lymphoma
C85.9,"Non-Hodgkin lymphoma, unspecified"
C86,Other specified types of T/NK-cell lymphoma
C86.0,"Extranodal NK/T-cell lymphoma, nasal type"
C86.1,Hepatosplenic T-cell lymphoma
C86.2,Enteropathy-type (intestinal) T-cell lymphoma
C86.3,Subcutaneous panniculitis-like T-cell lymphoma
C86.4,Blastic NK-cell lymphoma
C86.5,Angioimmunoblastic T-cell lymphoma
C86.6,Primary cutaneous CD30-positive T-cell proliferations
C88,Malignant immunoproliferative diseases
C88.0,Waldenstr├Âm macroglobulinaemia
C88.1,Alpha heavy chain disease
C88.2,Other heavy chain disease
C88.3,Immunoproliferative small intestinal disease
C88.4,Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
C88.7,Other malignant immunoproliferative diseases
C88.9,"Malignant immunoproliferative disease, unspecified"
C90,Multiple myeloma and malignant plasma cell neoplasms
C90.0,Multiple myeloma
C90.1,Plasma cell leukaemia
C90.2,Extramedullary plasmacytoma
C90.3,Solitary plasmacytoma
C91,Lymphoid leukaemia
C91.0,Acute lymphoblastic leukaemia [ALL]
C91.1,Chronic lymphocytic leukaemia of B-cell type
C91.2,Subacute lymphocytic leukaemia
C91.3,Prolymphocytic leukaemia of B-cell type
C91.4,Hairy-cell leukaemia
C91.5,Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
C91.6,Prolymphocytic leukaemia of T-cell type
C91.7,Other lymphoid leukaemia
C91.8,Mature B-cell leukaemia Burkitt-type
C91.9,"Lymphoid leukaemia, unspecified"
C92,Myeloid leukaemia
C92.0,Acute myeloblastic leukaemia [AML]
C92.1,"Chronic myeloid leukaemia [CML], BCR/ABL-positive"
C92.2,"Atypical chronic myeloid leukaemia, BCR/ABL-negative"
C92.3,Myeloid sarcoma
C92.4,Acute promyelocytic leukaemia [PML]
C92.5,Acute myelomonocytic leukaemia
C92.6,Acute myeloid leukaemia with 11q23-abnormality
C92.7,Other myeloid leukaemia
C92.8,Acute myeloid leukaemia with multilineage dysplasia
C92.9,"Myeloid leukaemia, unspecified"
C93,Monocytic leukaemia
C93.0,Acute monoblastic/monocytic leukaemia
C93.1,Chronic myelomonocytic leukaemia
C93.2,Subacute monocytic leukaemia
C93.3,Juvenile myelomonocytic leukaemia
C93.7,Other monocytic leukaemia
C93.9,"Monocytic leukaemia, unspecified"
C94,Other leukaemias of specified cell type
C94.0,Acute erythroid leukaemia
C94.1,Chronic erythraemia
C94.2,Acute megakaryoblastic leukaemia
C94.3,Mast cell leukaemia
C94.4,Acute panmyelosis with myelofibrosis
C94.5,Acute myelofibrosis
C94.6,"Myelodysplastic and myeloproliferative disease, not elsewhere classified"
C94.7,Other specified leukaemias
C95,Leukaemia of unspecified cell type
C95.0,Acute leukaemia of unspecified cell type
C95.1,Chronic leukaemia of unspecified cell type
C95.2,Subacute leukaemia unsp cell type
C95.7,Other leukaemia of unspecified cell type
C95.9,"Leukaemia, unspecified"
C96,"Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue"
C96.0,Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease]
C96.1,Malignant histiocytosis
C96.2,Malignant mast cell tumour
C96.3,True histiocyt lymphoma
C96.4,Sarcoma of dendritic cells (accessory cells)
C96.5,Multifocal and unisystemic Langerhans-cell histiocytosis
C96.6,Unifocal Langerhans-cell histiocytosis
C96.7,"Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue"
C96.8,Histiocytic sarcoma
C96.9,"Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified"
D46.6,Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
D46.7,Other myelodysplastic syndromes
D46.9,"Myelodysplastic syndrome, unspecified"
D47,"Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue"
D47.0,Histiocytic and mast cell tumours of uncertain and unknown behaviour
D47.1,Chronic myeloproliferative disease
D47.4,Osteomyelofibrosis
Z85.6,Personal history of leukaemia
Z85.7,"Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues"
D84.9,"Immunodeficiency, unspecified"
D89.9,"Disorder involving the immune mechanism, unspecified"
T45.1,Poisoning: Antineoplastic and immunosuppressive drugs
Y43.4,Immunosuppressive agents
,
T86.1,Kidney transplant failure and rejection
T86.2,Heart transplant failure and rejection
T86.3,Heart-lung transplant failure and rejection
T86.4,Liver transplant failure and rejection
Z94.0,Kidney transplant status
Z94.1,Heart transplant status
Z94.2,Lung transplant status
Z94.3,Heart and lungs transplant status
Z94.4,Liver transplant status
,
D81,Combined immunodeficiencies
D81.0,Severe combined immunodeficiency [SCID] with reticular dysgenesis
D81.1,Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
D81.2,Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
D81.3,Adenosine deaminase [ADA] deficiency
D81.4,Nezelof syndrome
D81.5,Purine nucleoside phosphorylase [PNP] deficiency
D81.6,Major histocompatibility complex class I deficiency
D81.7,Major histocompatibility complex class II deficiency
D81.8,Other combined immunodeficiencies
D81.9,"Combined immunodeficiency, unspecified"
D82,Immunodeficiency associated with other major defects
D82.0,Wiskott-Aldrich syndrome
D82.1,Di George syndrome
D82.2,Immunodeficiency with short-limbed stature
D82.3,Immunodeficiency following hereditary defective response to Epstein-Barr virus
D82.8,Immunodeficiency associated with other specified major defects
D82.9,"Immunodeficiency associated with major defect, unspecified"
D84.0,Lymphocyte function antigen-1 [LFA-1] defect
G11.3,Cerebellar ataxia with defective DNA repair